Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 40.72B P/E 118.99 EPS this Y 11.05% Ern Qtrly Grth 28.90%
Income 1.16B Forward P/E 26.66 EPS next Y 15.29% 50D Avg Chg 1.00%
Sales 9.76B PEG - EPS past 5Y - 200D Avg Chg 13.00%
Dividend N/A Price/Book 2.04 EPS next 5Y - 52W High Chg -5.00%
Recommedations 1.63 Quick Ratio 1.53 Shares Outstanding 494.60M 52W Low Chg 49.00%
Insider Own 0.14% ROA 2.55% Shares Float 493.54M Beta 0.73
Inst Own 66.45% ROE 5.59% Shares Shorted/Prior 3.19M/3.13M Price 82.10
Gross Margin 55.50% Profit Margin 11.89% Avg. Volume 777,345 Target Price 100.10
Oper. Margin 13.53% Earnings Date Feb 25 Volume 669,333 Change -1.86%
About Alcon Inc.

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, ARGOS biometer, LuxOR surgical ophthalmic microscope, SMARTCATARACT health platform, NGENUITY 3D visualization system, Verion reference unit and Verion digital marker, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantable products, including AcrySof IQ products, such as monofocal IOLs and advanced technology IOLs for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

Alcon Inc. News
12/31/24 Alcon to Present at 2025 Annual J.P. Morgan Healthcare Conference
12/23/24 Here's Why Alcon (ALC) is a Strong Growth Stock
12/17/24 Alcon Top Pick for 2025 at Needham, added to Conviction List
12/13/24 Reasons to Retain Alcon Stock in Your Portfolio for Now
12/06/24 Why Alcon (ALC) is a Top Growth Stock for the Long-Term
12/05/24 Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
12/03/24 Alcon Inc. (ALC): A Bull Case Theory
11/19/24 Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
11/18/24 Alcon (ALC) is a Top-Ranked Value Stock: Should You Buy?
11/14/24 Alcon Inc (ALC) Q3 2024 Earnings Call Highlights: Record Cash Flow and Strategic Product ...
11/13/24 Alcon Q3 Earnings Top Estimates, Margins Up, Stock Gains in Afterhours
11/12/24 Alcon (ALC) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
11/12/24 Alcon Reports Solid Third-Quarter 2024 Results, including Double-Digit Earnings Growth and Record Cash Generation
09:15 AM What Analyst Projections for Key Metrics Reveal About Alcon (ALC) Q3 Earnings
01:00 AM Alcon Debuts Groundbreaking PRECISION7, a One-Week Replacement Contact Lens to Start and End Every Week Fresh
10/30/24 Alcon Inc. (ALC): Among UBS’ Top Tech Based Disruptive Stocks For 2030
10/27/24 Alcon Singapore Elevates Associate Experience with Inspiring Engagement Programs
10/15/24 Alcon Innovations on Display at AAO 2024 Demonstrate Efficiency and Performance
09/20/24 Innovation Aids Alcon Stock's Growth Despite Macroeconomic Troubles
08/27/24 Alcon Inc. (ALC): One of Oppenheimer’s Top Stock Picks For the Next 12 Months